-
Product Insights
NewHistone Lysine N Methyltransferase EZH2 – Drugs In Development, 2024
The Histone Lysine N Methyltransferase EZH2 pipeline drugs market research report outlays comprehensive information on the Histone Lysine N Methyltransferase EZH2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Infectious Disease which include indications of Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Respiratory Syncytial Virus (RSV) Infections. It also reviews key players involved in Histone...
-
Product Insights
NewSialic Acid Binding Immunoglobulin Type Lectin – Drugs In Development, 2024
The Sialic Acid Binding Immunoglobulin Type Lectin pipeline drugs market research report outlays comprehensive information on the Sialic Acid Binding Immunoglobulin Type Lectin targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Immunology, and Ophthalmology which include indications of B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia),...
-
Product Insights
NewNonstructural Protein 5A – Drugs In Development, 2024
The Nonstructural Protein 5A pipeline drugs market research report outlays comprehensive information on the Nonstructural Protein 5A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, Oncology, Immunology, and Metabolic Disorders which include indications of Hepatitis C, Hepatitis B, Prostate Cancer, Melanoma, Inflammation, and Obesity. It also reviews key players involved in Nonstructural Protein 5A targeted...
-
Product Insights
NewLeukocyte Immunoglobulin Like Receptor Subfamily B Member 2 – Drugs In Development, 2024
The Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 pipeline drugs market research report outlays comprehensive information on the Leukocyte Immunoglobulin Like Receptor Subfamily B Member 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Central Nervous System which include indications of Solid Tumor, Melanoma, and Alzheimer's Disease. It also reviews key players involved in...
-
Product Insights
NewFree Fatty Acid Receptor 1 – Drugs In Development, 2024
The Free Fatty Acid Receptor 1 pipeline drugs market research report outlays comprehensive information on the Free Fatty Acid Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Gastrointestinal, Infectious Disease, and Central Nervous System which include indications of Type 2 Diabetes, Diabetes, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Hepatitis...
-
Product Insights
NewInhibitor of Nuclear Factor Kappa B Kinase Subunit Beta – Drugs In Development, 2024
The Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta pipeline drugs market research report outlays comprehensive information on the Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Genito Urinary System, and Gastrointestinal which include indications of Melanoma, Glioblastoma Multiforme (GBM), Inflammation, Acute Renal Failure (ARF)...
-
Product Insights
NewB And T Lymphocyte Attenuator – Drugs In Development, 2024
The B And T Lymphocyte Attenuator pipeline drugs market research report outlays comprehensive information on the B And T Lymphocyte Attenuator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, and Dermatology which include indications of Graft Versus Host Disease (GVHD), Autoimmune Disorders, Solid Tumor, Renal Cell Carcinoma, and Atopic Dermatitis (Atopic Eczema). It also reviews...
-
Product Insights
NewHepatitis B Virus DNA Polymerase – Drugs In Development, 2024
The Hepatitis B Virus DNA Polymerase pipeline drugs market research report outlays comprehensive information on the Hepatitis B Virus DNA Polymerase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease, and Undisclosed which include indications of Hepatitis B, and Unspecified. It also reviews key players involved in Hepatitis B Virus DNA Polymerase targeted therapeutics development with...
-
Product Insights
NewB Cell Lymphoma/Leukemia 11A – Drugs In Development, 2024
The B Cell Lymphoma/Leukemia 11A pipeline drugs market research report outlays comprehensive information on the B Cell Lymphoma/Leukemia 11A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hematological Disorders, and Oncology which include indications of Sickle Cell Disease, Beta Thalassaemia, and Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia). It also reviews key players involved in B Cell...
-
Product Insights
NewTumor Necrosis Factor Ligand Superfamily Member 4 – Drugs In Development, 2024
The Tumor Necrosis Factor Ligand Superfamily Member 4 pipeline drugs market research report outlays comprehensive information on the Tumor Necrosis Factor Ligand Superfamily Member 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Oncology, Respiratory, and Dermatology which include indications of Autoimmune Disorders, Rheumatoid Arthritis, Melanoma, Diffuse Large B-Cell Lymphoma, Asthma, Hidradenitis Suppurativa, and Atopic Dermatitis...